Molecular mechanisms of retroviral integration site selection
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Retroviral replication proceeds through an obligate integrated DNA provirus, making retroviral vectors attractive vehicles for human gene-therapy. Though most of the host cell genome is available for integration, the process of integration site selection is not random. Retroviruses differ in their choice of chromatin-associated features and also prefer particular nucleotide sequences at the point of insertion. Lentiviruses including HIV-1 preferentially integrate within the bodies of active genes, whereas the prototypical gammaretrovirus Moloney murine leukemia virus (MoMLV) favors strong enhancers and active gene promoter regions. Integration is catalyzed by the viral integrase protein, and recent research has demonstrated that HIV-1 and MoMLV targeting preferences are in large part guided by integrase-interacting host factors (LEDGF/p75 for HIV-1 and BET proteins for MoMLV) that tether viral intasomes to chromatin. In each case, the selectivity of epigenetic marks on histones recognized by the protein tether helps to determine the integration distribution. In contrast, nucleotide preferences at integration sites seem to be governed by the ability for the integrase protein to locally bend the DNA duplex for pairwise insertion of the viral DNA ends. We discuss approaches to alter integration site selection that could potentially improve the safety of retroviral vectors in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · cited 3×
“Two N-terminal bromodomains (BD-I and BDII) bind acetylated H3 and H4 tails on chromatin (85,86).”
BackgroundSelective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · cited 2×
“Independent studies suggested that enhancers are the major source of BRD4-dependent transcriptional activation (133) and that genes that are regulated by strong enhancers are particularly sensitive to BET inhibition (134).”
BackgroundMapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“In particular, MoMLV-based vectors have been successfully utilized in the treatment of primary immunodeficiencies (24,25).”
MethodInsertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854 · cited 2×
“However, adverse effects associated with integration of MoMLV-based vectors near proto-oncogenes were observed in these clinical trials (25–28).”
BackgroundHIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563 · cited 1×
“Small molecules JQ-1 and I-BET, which specifically impair interactions of all three BET proteins with cognate histone marks (86,101), were exploited to examine the role of BET proteins in MoMLV replication.”
BackgroundModification of Enhancer Chromatin: What, How, and Why?
Calo, E., & Wysocka, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.038 · Cited by 1,457 · cited 1×
“…that strong enhancers and active promoters are superior predictors of MoMLV integration as compared to TSSs. Clustered transcription factor binding sites essentially comprise enhancer elements, which function to form a platform for transcriptional regulatory complex recruitment (reviewed in 131).”
BackgroundIdentification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449 · cited 1×
“Genome-wide siRNA screens have identified cell host factors that are important for efficient HIV-1 infection (140–142).”
BackgroundSelf-citationTranscription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 2×
“Recent analysis of the consensus HIV-1 integration site (-3)TDG↓(G/V)TWA(C/B)CHA(7) highlighted the dinucleotide signature (0)RYXRY(4) at its center.”
BackgroundTransfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., et al. (2010) · Nature · doi:10.1038/nature09328 · Cited by 1,276
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 10×
“Accordingly, in vitro assays with purified INs have revealed that LEDGF / p75 significantly stimulated the strand transfer activities of lentiviral but not of other retro-viral INs (47,60,61,64).”
BackgroundInfluentialRetroviral intasome assembly and inhibition of DNA strand transfer
Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature08784 · Cited by 678 · cited 2×
“Highly conserved structural features of retroviral IN proteins include the catalytic triad of Asp, Asp and Glu (DDE) residues that coordinates a pair of essential Mg2+ ions during 3′ processing and strand transfer (32) and the Znbinding motif (HH-CC type) in the NTD that contributes to IN multimerization and DNA bindi…”
BackgroundSelf-citationA role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658 · cited 1×
“The first line of evidence for its role in HIV-1 target site selection emerged from the analysis of LEDGF/p75 knockdown cells, where significantly reduced frequencies of HIV-1 integration into active genes were observed even though these cells supported normal levels of HIV-1 infection (15,62).”
BackgroundHIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer
Engelman, A., Mizuuchi, K., & Craigie, R. (1991) · Cell · doi:10.1016/0092-8674(91)90297-c · Cited by 655
Self-citationMontini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
An essential role for LEDGF/p75 in HIV integration
Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W., & Poeschla, E. M. (2006) · Science · doi:10.1126/science.1132319 · Cited by 537
Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome
Boztug, K., Schmidt, M., Schwarzer, A., Banerjee, P. P., Díez, I. A., Dewey, R. A., Böhm, M., Nowrouzi, A., Ball, C. R., Glimm, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003548 · Cited by 532
LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells
Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., & Engelborghs, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303594200 · Cited by 493 · cited 4×
“These observations extended the prior finding that LEDGF/p75 was required for the chromosomal association of ectopically expressed HIV-1 IN in human cells (50).”
BackgroundResultInfluentialSchaller, T., Ocwieja, K. E., Rasaiyaah, J., Price, A. J., Brady, T. L., Roth, S. L., Hué, S., Fletcher, A. J., Lee, K., KewalRamani, V. N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002439 · Cited by 470 · cited 1×
“Moreover, a single missense mutation that resulted in an N74D change in HIV-1 CA counteracted the preference for HIV-1 to integrate into gene-rich regions of chromosomes (146,149).”
BackgroundCooperative binding of two acetylation marks on a histone tail by a single bromodomain
Morinière, J., Rousseaux, S., Steuerwald, U., Soler-López, M., Curtet, S., Vitte, A.-L., Govin, J., Gaucher, J., Sadoul, K., Hart, D. J., et al. (2009) · Nature · doi:10.1038/nature08397 · Cited by 469 · cited 1×
“Two N-terminal bromodomains (BD-I and BDII) bind acetylated H3 and H4 tails on chromatin (85,86).”
BackgroundShun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467 · cited 3×
“Interestingly, the wild-type level of HIV-1 PIC activity is maintained in samples isolated from LEDGF/p75 knockout cells (17).”
BackgroundMethodSelf-citationWang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C., & Bushman, F. D. (2007) · Genome Research · doi:10.1101/gr.6286907 · Cited by 457
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408
Self-citationRetroviral DNA integration: viral and cellular determinants of target-site selection
Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020060 · Cited by 364 · cited 3×
“Interestingly, these chimeric viruses displayed reduced integration frequencies in gene rich regions, which suggested a Gag-dependent role in integration site targeting (13,144,146).”
Retroviral DNA integration directed by HIV integration protein in vitro
Bushman, F. D., Fujiwara, T., & Craigie, R. (1990) · Science · doi:10.1126/science.2171144 · Cited by 338 · cited 1×
“During the following strand transfer reaction, IN uses these 3′-hydroxyl groups to generate a staggered cut in complementary strands of the target DNA and concomitantly join the viral DNA ends to the host genome (29,30).”
BackgroundCapsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells
Yamashita, M., & Emerman, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5670-5678.2004 · Cited by 325 · cited 1×
“The key HIV-1 determinant that governs PIC nuclear import is the viral capsid (CA) protein, which is expressed as part of the Gag structural precursor protein (137,139).”
BackgroundLlano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9524-9537.2004 · Cited by 305 · cited 7×
“Interestingly, the wild-type level of HIV-1 PIC activity is maintained in samples isolated from LEDGF / p75 knockout cells (17).”
BackgroundInfluentialThe mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296 · cited 3×
“Because PFV IN amino acids Ala188 in the CCD and Arg329 in the CTD interact with the eight bases of the target DNA consensus nucleotide signature that abut the central YR, the DNA palindrome represents preferentially bendable sequences that result from PFV INbase interactions and the centrally flexible YR sequence (31…”
BackgroundCherepanov, P., Devroe, E., Silver, P. A., & Engelman, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406307200 · Cited by 287
Self-citationMatreyek, K. A., Yücel, S. S., Li, X., & Engelman, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003693 · Cited by 280
Self-citationPryciak, P. M., & Varmus, H. E. (1992) · Cell · doi:10.1016/0092-8674(92)90289-o · Cited by 273
Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., & Bushman, F. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001340 · Cited by 241 · cited 3×
“Subsequent experiments using LEDGF/p75 knockout cells corroborated these findings and extended them to show that a significant percentage of HIV-1 proviruses were aberrantly located near TSSs in the absence of the host factor (16,17).”
BackgroundMethodSolution structure of the HIV-1 integrase-binding domain in LEDGF/p75
Cherepanov, P., Sun, Z.-Y. J., Rahman, S., Maertens, G., Wagner, G., & Engelman, A. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb937 · Cited by 235 · cited 1×
“A short interhelical loop from the IBD docks into a narrow, Vshaped cavity at the interface of two IN CCD molecules and establishes functionally critical hydrogen bonds between LEDGF/p75 hotspot residue Asp366 and the backbone amides of IN residues Glu170 and His171 (Figure 2B and C) (108,110).”
BackgroundSelf-citationHIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A. T., Chanda, S. K., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001313 · Cited by 212
The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding
Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., & Debyser, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411681200 · Cited by 208
Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes
Eidahl, J. O., Crowe, B. L., North, J. A., McKee, C. J., Shkriabai, N., Feng, L., Plumb, M., Graham, R. L., Gorelick, R. J., Hess, S., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt074 · Cited by 207 · cited 2×
“NMR structures of the LEDGF/p75 PWWP domain revealed two distinct functional interfaces: a well-defined hydrophobic pocket that interacts with the H3K36me3 histone tail, and an adjacent basic interface that non-specifically engages DNA (120,121).”
BackgroundSelf-citationLlano, M., Vanegas, M., Hutchins, N., Thompson, D., Delgado, S., & Poeschla, E. M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.073 · Cited by 199
BET proteins promote efficient murine leukemia virus integration at transcription start sites
Sharma, A., Larue, R. C., Plumb, M. R., Malani, N., Male, F., Slaughter, A., Kessl, J. J., Shkriabai, N., Coward, E., Aiyer, S. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307157110 · Cited by 193 · cited 10×
“did not detect any binding to a CTD deletion mutant of MoMLV IN (19), Gupta et al.”
BackgroundMethodInfluentialSelf-citationTurlure, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl052 · Cited by 181 · cited 11×
“Accordingly, in vitro assays with purified INs have revealed that LEDGF / p75 significantly stimulated the strand transfer activities of lentiviral but not of other retro-viral INs (47,60,61,64).”
BackgroundInfluentialDe Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F. D., Landuyt, B., Husson, S. J., Busschots, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.040 · Cited by 175
The influence of DNA and nucleosome structure on integration events directed by HIV integrase
Pruss, D., Reeves, R., Bushman, F. D., & Wolffe, A. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31494-1 · Cited by 173
Cherepanov, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl885 · Cited by 173
New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347534 · Cited by 167 · cited 1×
“As discussed, the LEDGF / p75 IBD engages IN at the CCD-CCD dimer interface (108) (Figure 2C), which is also the binding site of a potent class of small molecule inhibitors that promote IN multimerization and inhibit HIV-1 IN catalysis in vitro (116–118).”
BackgroundHare, S., Shun, M.-C., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000259 · Cited by 166 · cited 2×
“Electrostatic interactions between the HIV-1 IN NTD and LEDGF/p75 IBD, which are important for the high affinity interaction, have been scrutinized to artificially control HIV-1 integration site selectivity (109,182).”
BackgroundSelf-citationHolman, A. G., & Coffin, J. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501646102 · Cited by 164
3′‐Processing and strand transfer catalysed by retroviral integrase in crystallo
Hare, S., Maertens, G. N., & Cherepanov, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.118 · Cited by 153 · cited 2×
“…IN proteins include the catalytic triad of Asp, Asp and Glu (DDE) residues that coordinates a pair of essential Mg 2+ ions during 3 processing and strand transfer (32) and the Zn-binding motif (HH-CC type) in the NTD that contributes to IN multimerization and DNA binding (102,103) (Figure 2A).”
BackgroundGupta, S. S., Maetzig, T., Maertens, G. N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., & Schulz, T. F. (2013) · Journal of Virology · doi:10.1128/jvi.01942-13 · Cited by 139
Retroviral integration and human gene therapy
Bushman, F. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32949 · Cited by 138 · cited 2×
“Retroviruses present efficient vehicles for the delivery of therapeutic genes due to their trait of stable DNA integration and because they are amenable to pseudotyping with a variety of envelope glycoproteins (1,22,23).”
BackgroundFunctional and structural characterization of the integrase from the prototype foamy virus
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn938 · Cited by 130 · cited 10×
“These studies in turn suggest that the overall architectures of different retroviral intasomes may exhibit significant resemblance with the PFV structure.”
MethodInfluentialStructural Basis for Functional Tetramerization of Lentiviral Integrase
Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000515 · Cited by 122
Self-citationMLV integration site selection is driven by strong enhancers and active promoters
LaFave, M. C., Varshney, G. K., Gildea, D. E., Wolfsberg, T. G., Baxevanis, A. D., & Burgess, S. M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1399 · Cited by 114 · cited 3×
“However, the precise hierarchy of favored histone modifications varied among cell type (8,9), which likely recapitulates the observation that the activities of many enhancers are cell-type specific (132).”
BackgroundStem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
Wu, C., & Dunbar, C. E. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0159-1 · Cited by 114 · cited 2×
“Unfortunately, severe adverse events occurred in five of the 20 patients, who developed leukemia (158).”
BackgroundMethodEnhancers Are Major Targets for Murine Leukemia Virus Vector Integration
De Ravin, S. S., Su, L., Theobald, N., Choi, U., Macpherson, J. L., Poidinger, M., Symonds, G., Pond, S. M., Ferris, A. L., Hughes, S. H., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00011-14 · Cited by 103 · cited 7×
“Recent reports that significantly extended the number of unique MoMLV integration sites analyzed ( ∼ 3.9 million) have yielded novel insight into the mechanism of MoMLV PIC targeting (8,9).”
BackgroundResultInfluentialSequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration
Stevens, S. W., & Griffith, J. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6459-6462.1996 · Cited by 96
Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins
LeRoy, G., Chepelev, I., DiMaggio, P. A., Blanco, M. A., Zee, B. M., Zhao, K., & Garcia, B. A. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-r68 · Cited by 84 · cited 2×
“The chromatin binding sites of BET proteins have been mapped using ChIP-Seq experiments (100), which when compared with retroviral integration sites showed a positive correlation with MoMLV but not with HIV-1 or ASLV (19,21).”
BackgroundMethodShun, M.-C., Botbol, Y., Li, X., Di Nunzio, F., Daigle, J. E., Yan, N., Lieberman, J., Lavigne, M., & Engelman, A. (2008) · Journal of Virology · doi:10.1128/jvi.01561-08 · Cited by 78 · cited 1×
“Indeed, mutations introduced in either the hydrophobic pocket or the basic surface significantly compromised the ability of LEDGF/p75 to both associate with chromatin and stimulate HIV-1 integration (128).”
Self-citationp12 Tethers the Murine Leukemia Virus Pre-integration Complex to Mitotic Chromosomes
Elis, E., Ehrlich, M., Prizan-Ravid, A., Laham-Karam, N., & Bacharach, E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003103 · Cited by 76
Aiyer, S., Swapna, G. V. T., Malani, N., Aramini, J. M., Schneider, W. M., Plumb, M. R., Ghanem, M., Larue, R. C., Sharma, A., Studamire, B., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku175 · Cited by 72
Self-citationGammaretroviral Integration into Nucleosomal Target DNA In Vivo
Roth, S. L., Malani, N., & Bushman, F. D. (2011) · Journal of Virology · doi:10.1128/jvi.00635-11 · Cited by 69
Serrao, E., Krishnan, L., Shun, M.-C., Li, X., Cherepanov, P., Engelman, A., & Maertens, G. N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku136 · Cited by 59
Self-citationSchneider, W. M., Brzezinski, J. D., Aiyer, S., Malani, N., Gyuricza, M., Bushman, F. D., & Roth, M. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221736110 · Cited by 49 · cited 1×
“However, mutations that altered p12 interactions with chromatin had no detectable effects on MoMLV integration target site selection (152).”
Background
Cited by
Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration
Klompe, S. E., Vo, P. L. H., Halpin-Healy, T. S., & Sternberg, S. H. (2019) · Nature · doi:10.1038/s41586-019-1323-z · Cited by 627
Sowd, G. A., Serrao, E., Wang, H., Wang, W., Fadel, H. J., Poeschla, E. M., & Engelman, A. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524213113 · Cited by 249
Self-citationBejarano, D. A., Peng, K., Laketa, V., Börner, K., Jost, K. L., Lucic, B., Glass, B., Lusic, M., Müller, B., & Kräusslich, H.-G. (2019) · eLife · doi:10.7554/elife.41800 · Cited by 197
Fontana, J., Jurado, K. A., Cheng, N., Ly, N. L., Fuchs, J. R., Gorelick, R. J., Engelman, A. N., & Steven, A. C. (2015) · Journal of Virology · doi:10.1128/jvi.01522-15 · Cited by 96
Self-citationCrowe, B. L., Larue, R. C., Yuan, C., Hess, S., Kvaratskhelia, M., & Foster, M. P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516813113 · Cited by 83
Self-citation
Metadata
- Authors
- Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-21
- Volume
- 42
- Issue
- 16
- Pages
- 10209-10225
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2112702228
- Cited by
- 135
- References
- 63
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.